Other Species / Isoforms
  EGLN1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MANDsGGPGGPs
0 1
EGLN1 (human) ___MANDsGGPGGPs S5-p
EGLN1 (mouse) ___MASDSGGPGVLS S5
EGLN1 (rat) gap -
S12-p
sGGPGGPsPSERDRQ
0 4
EGLN1 (human) sGGPGGPsPSERDRQ S12-p
EGLN1 (mouse) SGGPGVLSASERDRQ S12
EGLN1 (rat) gap -
S61-p
HKLVCQGsEGALGHG
0 1
EGLN1 (human) HKLVCQGsEGALGHG S61-p
EGLN1 (mouse) HKLVCQGGEAPRAQP G61
EGLN1 (rat) gap -
S125-p
ADPAAAAsPCRAAAG
Upstream
Downstream
1 28
Effects on Modified Protein
  • enzymatic activity, induced
  • protein degradation
Effects on Biological Processes:
  • apoptosis, induced
  • cell growth, inhibited
Phosphatases, in vitro:
  • PPP2CA (human)
Putative in vivo kinases:
  • p70S6K (human)
Putative upstream phosphatases:
  • PPP2R2A (human)
Treatment
  • hypoxia
  • ischemia
EGLN1 (human) ADPAAAAsPCRAAAG S125-p
EGLN1 (mouse) gap -
EGLN1 (rat) gap -
R152
GKEEPPARSSLFQEK
0 1
EGLN1 (human) GKEEPPARSSLFQEK R152
EGLN1 (mouse) GSEDPPLsRsPGPER S129-p
EGLN1 (rat) gap -
S154
EEPPARSSLFQEKAN
0 2
EGLN1 (human) EEPPARSSLFQEKAN S154
EGLN1 (mouse) EDPPLsRsPGPERAS S131-p
EGLN1 (rat) gap -
Y163-p
FQEKANLyPPSNTPG
0 1
EGLN1 (human) FQEKANLyPPSNTPG Y163-p
EGLN1 (mouse) GPERASLCPAGGGPG C140
EGLN1 (rat) gap -
S174-p
NTPGDALsPGGGLRP
0 2
EGLN1 (human) NTPGDALsPGGGLRP S174-p
EGLN1 (mouse) GGPGEALSPGGGLRP S151
EGLN1 (rat) gap -
K216-ub
VVDDFLGkETGQQIG
0 1
EGLN1 (human) VVDDFLGkETGQQIG K216-ub
EGLN1 (mouse) VVDDFLGRETGQQIG R193
EGLN1 (rat) VVDDFLGRETGQQIG R15
T232-p
EVRALHDtGkFTDGQ
0 1
EGLN1 (human) EVRALHDtGkFTDGQ T232-p
EGLN1 (mouse) EVRALHDTGKFTDGQ T209
EGLN1 (rat) EVRALHDTGKFTDGQ T31
K234-ub
RALHDtGkFTDGQLV
0 2
EGLN1 (human) RALHDtGkFTDGQLV K234-ub
EGLN1 (mouse) RALHDTGKFTDGQLV K211
EGLN1 (rat) RALHDTGKFTDGQLV K33
K244-ub
DGQLVSQkSDSSKDI
0 1
EGLN1 (human) DGQLVSQkSDSSKDI K244-ub
EGLN1 (mouse) DGQLVSQKSDSSKDI K221
EGLN1 (rat) DGQLVSQKSDSSKDI K43
K244-m1
DGQLVSQkSDSSKDI
0 1
EGLN1 (human) DGQLVSQkSDSSKDI K244-m1
EGLN1 (mouse) DGQLVSQKSDSSKDI K221
EGLN1 (rat) DGQLVSQKSDSSKDI K43
K255-ub
SKDIRGDkITWIEGK
0 1
EGLN1 (human) SKDIRGDkITWIEGK K255-ub
EGLN1 (mouse) SKDIRGDQITWIEGK Q232
EGLN1 (rat) SKDIRGDKITWIEGK K54
K286-ub
LIRHCNGkLGSYKIN
0 1
EGLN1 (human) LIRHCNGkLGSYKIN K286-ub
EGLN1 (mouse) LIRHCSGKLGNYRIN K263
EGLN1 (rat) LIRHCSGKLGNYRIN K85
K337-ub
LNKDWDAkVSGGILR
0 1
EGLN1 (human) LNKDWDAkVSGGILR K337-ub
EGLN1 (mouse) LNKDWDAKVSGGILR K314
EGLN1 (rat) LNKDWDAKVSGGILR K136
K350-ub
LRIFPEGkAQFADIE
0 1
EGLN1 (human) LRIFPEGkAQFADIE K350-ub
EGLN1 (mouse) LRIFPEGKAQFADIE K327
EGLN1 (rat) LRIFPEGKAQFADIE K149
K402-ub
ERARAKVkYLtGEkG
0 1
EGLN1 (human) ERARAKVkYLtGEkG K402-ub
EGLN1 (mouse) ERARAKVKYLTGEKG K379
EGLN1 (rat) ERARAKVKYLTGEKG K201
T405-p
RAKVkYLtGEkGVRV
0 1
EGLN1 (human) RAKVkYLtGEkGVRV T405-p
EGLN1 (mouse) RAKVKYLTGEKGVRV T382
EGLN1 (rat) RAKVKYLTGEKGVRV T204
K408-ac
VkYLtGEkGVRVELN
0 1
EGLN1 (human) VkYLtGEkGVRVELN K408-ac
EGLN1 (mouse) VKYLTGEKGVRVELK K385
EGLN1 (rat) VKYLTGEKGVRVELK K207
K408-ub
VkYLtGEkGVRVELN
0 1
EGLN1 (human) VkYLtGEkGVRVELN K408-ub
EGLN1 (mouse) VKYLTGEKGVRVELK K385
EGLN1 (rat) VKYLTGEKGVRVELK K207
K416-ub
GVRVELNkPSDSVGK
0 1
EGLN1 (human) GVRVELNkPSDSVGK K416-ub
EGLN1 (mouse) under review -
EGLN1 (rat) under review -